ReviewBiomedical reports2026
Potential of organ-on-a-chip in advancing synthetic extracellular matrix technology for bone tissue engineering in dentistry (Review).
Review in Biomedical reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bone tissue engineering (BTE) is a cutting-edge approach within biomedical sciences, especially in regenerative medicine, addressing key challenges such as organ transplantation and complex tissue repair. At the core of BTE is the development of biomimetic scaffolds to replicate native tissue environments. However, conventional models often fall short in accurately mimicking the complexity of human tissue microenvironments. Organ-on-a-chip (OOAC) technology offers a transformative alternative. These microscale systems combine microfluidics, biomaterials and cell cultures to emulate the structural and functional characteristics of human tissue. OOAC platforms facilitate dynamic, real-time evaluation of scaffold biocompatibility, cellular interactions and mechanical properties under physiological conditions. By overcoming the limitations of traditional preclinical models, OOAC systems minimize the need for animal testing, improve predictive accuracy for
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.